Lncrna FOXD2-AS1 Was a Key Part in Thyroid Cancer Biological Activity

Shi Guohua,Bu Zibin,Lou Cen
DOI: https://doi.org/10.1166/jbt.2019.2098
2019-01-01
Journal of Biomaterials and Tissue Engineering
Abstract:Objective: The research was wanted to discuss the effect lncRNA FOXD2-AS1 on Thyroid Cancer Biological Activity. Methods: The cells were respectively divided as NC and si-FOXD2-AS1 groups. Measuring the FOXD2-AS1 mRNA expression in difference cell lines by RT-qPCR. The cell proliferation rate were evaluated by CCK-8; Using flow cytometry to measure cell apoptosis; Using transwell and wound healing methods to evaluate invasion and migration abilities. The relative proteins levels were measured by WB assay. Results: With si-FOXD2-AS1 transfection, the FOXD2-AS1 mRNA expression of si-FOXD2-AS1 groups were significantly down-regulation (P < 0.001); Cell proliferation rate of si-FOXD2-AS1 groups were significantly depressed with cell apoptosis significantly increased (P < 0.001); The invasion and migration abilities of si-FOXD2-AS1 groups were significantly suppressed (P < 0.001). By WB assay, GRP94, cyclin D1, β-catenin and c-Myc proteins expressions of si-FOXD2-AS1 groups were significantly down-regulation (P < 0.001). Conclusion: lncRNA FOXD2-AS1 was as oncology role in Thyroid Cancer occur, FOXD2-AS1 knockdown had effects to suppress Thyroid Cancer.
What problem does this paper attempt to address?